Pfizer signs $43 bln Seagen deal in cancer drug push

on Monday struck a roughly $43 billion deal for Seagen Inc (SGEN.O) to bulk up its cancer treatments portfolio, as the drugmaker braces for a steep fall in COVID-19 product sales and loss of exclusivity for some top sellers. The deal, Pfizer's biggest in a string of acquisitions after a…#pfizerinc #seageninc #pfizer #seagen #wellsfargo #mohitbansal #pfizerrival #merckcoinc #manasmishra #bhanvisatija
Source: Reuters: Health - Category: Consumer Health News Source Type: news